Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[18F]AlF-NOTA-RIDGE11
- Development stage
- Unknown
- Lead developer
- Southern Medical University
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals
01
Overview
[18F]AlF-NOTA-RIDGE11: sourced facts only. name: "This study developed a novel peptide-based PET probe targeting EGFR, [18F]AlF-NOTA-RIDGE11, by conjugating a NOTA chelator to the D-type retro-inverso isomer of LGE11 (RIDGE11) to enhance metabolic stability." [PMID:41015348]; target: "This study developed a novel peptide-based PET probe targeting EGFR, [18F]AlF-NOTA-RIDGE11, by conjugating a NOTA chelator to the D-type retro-inverso isomer of LGE11 (RIDGE11) to enhance metabolic stability." [PMID:41015348]; developer: "Department of Nuclear Medicine, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China.; PET Center and Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China." [PMID:41015348]; modality: "This study developed a novel peptide-based PET probe targeting EGFR, [18F]AlF-NOTA-RIDGE11, by conjugating a NOTA chelator to the D-type retro-inverso isomer of LGE11 (RIDGE11) to enhance metabolic stability." [PMID:41015348]
02
Targets
Beyond the preview
Go deeper on [18F]AlF-NOTA-RIDGE11.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [18F]AlF-NOTA-RIDGE11.